1.The influence of fasudil on the serum hs-CRP and SAA in the treatments of patients with acute cerebral infarction
Jing LI ; Junsheng FAN ; Yanli LI
Chinese Journal of Primary Medicine and Pharmacy 2013;20(1):49-51
Objective To study the effectiveness of fasudil on the serum high sensitive C-reactive protein (hs-CRP) and serum amyloid A (SAA) in the patients with acute cerebral infarction.Methods 100 patients with acute cerebral infarction were randomly divided into two groups,the control group (n =50 cases) and the treatment group(n =50 cases).The patients in the control group were treated through salvia injection,while the patients in the treatment group were treated through fasudil.They were treated for forteen days.The hs-CRP and SAA in the serum were detected before and after treatment.Results The total efficienties were 92% in the treatment group and 84% in the control group.There was a significant difference between two groups(x2 =1.5152,P < 0.05).The treatment group before and after treament with hs-CRP were (11.3 ± 3.7) mg/L,(3.6 ± 1.1) mg/L.The control group before and after treatment with hs-CRP were (10.9 ± 3.5) mg/L,(7.2 ± 2.8) mg/L.Before and after treatment two groups had significant difference (t =14.1053,P < 0.01) ; after the treatment in the two groups had significant diffecence (t =8.4618,P < 0.05).The treatment group before and after treatment with SAA were (17.6 ± 5.2) mg/L,(2.7 ± 0.9)mg/L,control group before and after SAA treatment were (17.1 ± 4.9) mg/L,(5.2 ± 1.8) mg/L.Before and after treatment,two groups had significant difference (t =2.0096,2.0096,all P < 0.01) ; after the treatment in the two groups had significant difference(t =8.7841,P < 0.05).Conclusion Fasudil can improve acute cerebral infarction throughmitigating inflammation.
2.Practice and application of big data in biomedical research
Ning ZHANG ; Yuanxu XU ; Fan YANG ; Yaling LIAO ; Junsheng JI
Chinese Journal of Medical Science Research Management 2015;28(1):2-4
With the growing awearness of Big data and its application in economic,social and scientific fields,this paper analyzed the impact and challenges big data has brought to the field of biomedical research,and put forward suggestion of improving applications of big data in biomedical research.
3.Study of high-resolution ultrasonographic evaluation of peripheral nerve lesion in extremities
Junsheng FAN ; Zhenguo LAO ; Xiaoyan XIE ; Al ET
Chinese Journal of Microsurgery 2000;0(04):-
Objective To evaluate the diagnostic value of high resolution ultrasonography in peripheral nerve lesions Methods Sonographic examinations of peripheral nerves with 10 MHz probe were performed in vitro (fresh amputated specimen), in vivo (healthy volunteers), and in 28 patients with peripheral nerve lesions caused by trauma, compression and tumors preoperatively Sonograms were compared with the corresponding intraoperative findings Results The normal nerve displayed and echogenic fascicular texture with round to oval corss sectional structure on both in vitro and in vivo sonograms In traumatic lesions, the interruption of fascicular pattern reflected the disruption of nerve, and ill delineated fascicular pattern indicated nerve adhesion Centrally hypoechoic and peripherally hyperechoic changes were seen in compressive lesions Definitive relations between nerve and tumor were demonstrated in case of nerve tumor The diagnostic rate by ultrasonography was 64% when the intraoperative findings were regarded as criteria Conclusion Ultrasonography is of some diagnostic value and may have great potential to help direct treatment and follow up in peripheral nerve lesions
4.Study of the relationship between antibody level and protection induced by human papillomavirus(HPV) L2-peptide
Xueling WU ; Junsheng CUI ; Shufang MENG ; Baowei LI ; Chuntao ZHANG ; Jinping FAN ; Rongguang SHAO ; Youchun WANG
Chinese Journal of Microbiology and Immunology 2010;30(2):159-163
Objective To detect the protection induced by HPV-58 L2 11-200 AA in animal, and analyze the relationship between antibody or neutralizing antibody titers and the protection generated by the immunizmg agent. Methods The peptide of HPV-58 L2 11-200 AA was expressed in E. coli and the mice were immunized with the peptide after purification and adsorption with aluminum adjuvant. The protection provided by different immunizing doses was detected in the mouse model against the challenge of the pseud-ovirions of human papiilomavirus types 58. The total antibodies and neutralizing antibody titers of serum were tested with ELISA and neutralization assay against HPV-58 pseudovirus, respectively. The total antibodies or neutralizing antibody titers that can protect the mouse from infection were analyzed. Results The mice can be protected from the challenge with HPV pseudovirus when the immunizing dose was 8 μg. The neutralizing antibody can not be detected in the immune serum by neutralization assay against pseudovirus. The total anti-body level has a corresponding relationship with the protection showed in mouse model. The results of total antibodies detected by ELISA showed that when the titer of total antibodies was ≥25 000, luminescent signal can not be detected and the mice can be protected from pseudovirus infection. Conclusion HPV-58 L2 11-200 AA peptide can protect mice from pseudovirus infection. L2 peptide has a promising perspective to be a candidate vaccine and the level of total antibodies in the immune serum can be used as a surrogate for the evaluation of protection against HPV infection.
5.Effects of ecoimmunonutrition on intestinal barrier and pancreas in rats with severe acute pancreatitis
Zhonghui LIU ; Yanping DU ; Chujun LI ; Huashe WANG ; Yun LI ; Xinjuan FAN ; Haihua LUO ; Junsheng PENG
Chinese Journal of Clinical Nutrition 2010;18(2):106-110,illust 2
Objective To explore the effects of ecoimmunonutrition support on the intestinal barrier function and pancreas in rats with severe acute pancreatitis (SAP). Methods Totally 64 SPF rats were randomly divided into sham operation group (control group) , SAP without enteral nutrition support group (SAP group), SAP with early enteral nutrition support group (EEN group), and SAP with early ecoimmunonutrition support group (EIN group). Bacteria translocation (BT), plasma endotoxin (ET) , gut permeability, pancreas pathology score,and distant ileum pathology were determined on the 4th and 7th post-modeling day. Results The BT rate was significantly higher in SAP group, EEN group, and EIN group than in control group (P < 0.05), was significantly lower in EEN group and EIN group than in SAP group (P < 0.05), and was significantly lower in EIN group than in EEN group (P < 0.05). ET and FD-40 levels in blood were both significantly higher in SAP group, EEN group, and EIN group than in control group (P <0.01)and were significantly lower in EIN group and EEN group than in SAP group (P <0.01); ET was significantly lower in EIN group than in control group (P <0.05). Pathological scores were significantly higher in SAP group, EEN group, and EIN group than in control group (P <0.01)and were significantly lower in EEN group and EIN group than in SAP group (P < 0.01). The individual pathological scores of EIN group were not significantly different from EEN group (P > 0.05), while the total score was significantly lower in EIN group than in EEN group (P > 0.05). Distant iliac mucosa was significantly thicker in EIN group than in other groups. Conclusions Early enteral nutrition support protects the intestinal barrier and pancreas in rats with SAP. Ecoimmunonutrition has better nutritional effectiveness than the normal enteral nutrition.
6.The management and risk factors of pericardial effusion after cardiac surgery
Junsheng MU ; Jianqun ZHANG ; Fan ZHOU ; Chengxiong GU ; Fangjiong HUANG ; Xu MENG ; Lizhong SUN ; Hongjia ZHANG ; Ping BO ; Bin YOU ; Ran DONG
Chinese Journal of Thoracic and Cardiovascular Surgery 2011;27(11):668-670
Objective We aimed to recent experience at our hospital in the diagnosis and treatment of pericardial effusion after cardiac surgery and to identify risk factors for its development.Methods We searched our hospital for patient who had cardiac surgery with cardiopulmonary bypass from January 2002 through December 2010.For patient with pericardial effusion,medical records were reviewed to evaluate its manifestations and management.To identify risk factors for effusion,patients with effusions were compared with patients without effusions.All patients had routine postoperative echocardiographic examination.Results Of 22462 patients identified,509 (2.3%) had pericardial effusion.Compared with patients without pericardial effusion,ages,sex,cardiac function and so on were no significant( P > 0.05 ).Body,valve cardiac diseases,and cardiopulmonary bypass time and so on were significant ( P < 0.05 ).Among 509 patients with pericardial effusion,262 patients (51.4%) of whom had specific symptoms.Clinical features of tamponade were documented in 51 patients( 10.1% ).Pericardial effusions were evacuated by echocardilgraphy-guided pericardiocentesis ( n =27,10.3% ) or surgical drainage ( n =15,5.7% ).Pericardial effusion resolved after left thoracocentesis for pleural effusion in 5 patients ( 1.9% ) ; The Other patients with pericardial effusion were treated conservatively.Indeperdent risk factors for pericardial effusion were large body,valve cardiac operations,and prolonged cardiopulmonsry bypass.Conclusion In our study,pericardial effusion occurred in 2.3% of patients,and symptoms were nonspecific.Several factors,mainly related to preoperative characteristics and type of operation,predispose patients to effusion,echocardiography-guided pericardiocentesis is effective and safe in these patients with pericardial effusion.
8.Initial experience of ileal ureter replacement combined with augmentation cystoplasty in the treatment of ureteral stenosis with contracted bladder
Kunlin YANG ; Yuye WU ; Guangpu DING ; Yukun CAI ; Wei SHI ; Junsheng BAO ; Wenfeng GUAN ; Zi'ao LI ; Shubo FAN ; Wanqiang LI ; Lei ZHANG ; Xuesong LI ; Liqun ZHOU
Chinese Journal of Urology 2019;40(6):416-421
Objective To explore the availability and safety of ileal ureter replacement combined with ileal augmentation cystoplasty in treating ureteral stenosis with contracted bladder.Methods From August 2015 to November 2018,three patients who underwent ileal ureter replacement combined with augmentation cystoplasty were treated with ileal ureter replacement combined with augmentation cystoplasty.There were 1 male and 2 females with the age ranging from 34 to 55 years (mean 39 years).Two patients suffered from left ureter stenosis,and one patient had stenosis on the both sides.The length of the ureter stenosis ranged from 6 to 18 cm (mean 9.8 cm).The preoperative bladder capacity ranged from 60 to 150 ml (mean 103.3 ml).In the surgery,part of ileum was used to replace the ureter,and the distal intestine was made into U-shape to enlarge the bladder.Results All operation were completed successfully.The operation time ranged from 220 to 400 min (mean 303.0 min),and the blood loss ranged from 150 to 500 ml (mean 283.3 ml).Laparoscopic surgery was performed in 1 case and open surgery in 2 cases.Three weeks after the surgery,the bladder volume underwent cystography ranged from 300 to 400 ml (mean 360.0 ml).Three months after the surgery,the postvoid residual urine volume ranged from 20 to 50 ml (mean 33.3 ml).Postoperative frequency and urgency of urine were completely relieved in 1 case,alleviated in 2 cases.Flank pain was completely relieved in 1 case,and alleviated in 2 cases postoperatively.The serum creatinine of 2 patients mildly increased after the surgery,while 1 patient remained stable.For complications,1 patient had urinary infection,and 1 patient suffered from metabolic acidosis.Conclusions Ileal ureteral replacement combined with augmentation cystoplasty can be the choice of treatment for long segment ureteral stenosis and enlarge the bladder simultaneously.The postoperative complications and the kidney functions should be regularly followed up.
9.Cardiac surgical operation after renal transplantation.
Junsheng MU ; Fan ZHOU ; Xianshuai LI ; Jianqun ZHANG ; Ping BO
Chinese Medical Journal 2014;127(10):1990-1991
10.Da Chengqitang in Treatment of Sepsis: A Review
Junsheng SHA ; Nan ZHANG ; Weiyi SUN ; Xiang LI ; Shifa YANG ; Qiang ZHI ; Shu CHEN ; Nan GAO ; Liyan FAN
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(17):274-282
Sepsis is a systemic inflammatory syndrome induced by infection and other factors, with the number of patients worldwide exceeding 10 million each year. The pathophysiological mechanism is of this disease complex. Sepsis is often accompanied by endotoxin translocation, gastrointestinal dysfunction, inflammatory cytokine activation, immune dysregulation, coagulation disorder, multiple organ function impairment and many other body imbalances, as well as systemic inflammation, apoptosis, oxidative stress injury and other cell damage mechanisms. This disease causes a heavy medical burden due to the difficult diagnosis and treatment and the poor prognosis. Great progress has been achieved in the diagnosis and treatment of sepsis with traditional Chinese medicine (TCM) and western medicine. The value of western medicine in the diagnosis and treatment of sepsis is limited due to antibiotic resistance, hormone abuse, and high medical costs. Sepsis is classified as a warm disease or typhoid fever in TCM. Da Chengqitang is a classical formula in the Treatise on Typhoid Fever to deal with the excess syndrome of Yang brightness Fu-organ. Modern medicine has proved that Da Chengqitang has the effect of inhibiting oxidative stress, reducing inflammation, and delaying apoptosis by improving gastrointestinal dynamics and regulating intestinal microecology. On the basis of the previous theoretical basis and the rich experience in the medication, medical practitioners have proposed a new therapeutic concept of using Da Chengqitang in combination with western drugs from a holistic view involving both bacteria and toxicity for treating both the symptoms and the root cause, which has a wide range of application. The article reviews the classical research and latest findings of Da Chengqitang in the treatment of sepsis, with a view to clarifying the mechanism and advantages of this formula in the adjuvant treatment of sepsis, exploring its potential efficacy, and providing timely, adequate, and scientific theoretical support for the promotion of this formula in the clinical practice.